[SCHEDULE 13G/A Amendment No. 12 China Cord Blood Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 698659109 (CUSIP Number) March 30, 2017 (Date of Event Which Requires Filing of this Statement) ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) *The ]
[UTStarcom Announces Receipt of a Preliminary Non-Binding Proposal i Hong Kong, March 31, 2017 UTStarcom Holdings Corp. (NASDAQ: UTSI) (the Company or UTStarcom) today announced that its board of directors (the Board) has received a preliminary non-binding proposal letter, dated March 31, 201]
[] [Loans Extension Confirmation Letter Reference is made to the loans from Ms. Heung Mei Tsui to China Pharma Holdings, Inc. (the “Company”), the principal and accumulated interest totaled USD1,354,567 and USD71,303.91 respectively as of December 31, 2016. Due to the fact the Company temporarily did]
[Fang Announces Fourth Quarter and Fiscal Year 2016 Results BEIJING, March 31, 2017 /PRNewswire/ -- Fang Holdings Limited (NYSE: SFUN) ("Fang" or "we"), the leading real estate Internet portal in China, today announced its unaudited financial results for fourth quarter and fiscal year ended December ]
[Joint Filing Agreement 13d-1(k) In accordance with Rule [Remainder of this page has been left intentionally blank.] Shah Capital Opportunity Fund LP Shah Capital LLC, the General Partner Himanshu H. Shah Managing Member Himanshu H. Shah Himanshu H. Shah Hong Liang Lu Hong Liang Lu Lu Charitable Rema]
[FORM 20-F (Mark One) o OR x OR o For the transition period from to OR o Date of event requiring this shell company report . . . . . . . . . . . . . . . . . . . 51job, Inc. N/A Cayman Islands (Jurisdiction of incorporation or organization) Building 3 No. 1387, Zhang Dong] [List of Subsidiaries and Af]
[Contact: China Pharma Holdings, Inc. Ms. Diana Na Huang Phone: +86-898-6681-1730 (China) Email: hps@chinapharmaholdings.com China Pharma Holdings, Inc. Reports Full Year 2016 Financial Results HAIKOU CITY, China, March 31, 2017 - China Pharma Holdings, Inc. (NYSE MKT: CPHI) (“China Pharma,” the “Com]
[FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): CUSIP NUMBER [ x ] Form 10-K [ For Period Ended: December 31, 2016 [ Transition Report on Form 10-K [ Transition Report on Form 20-F [ Transition Report on Form 11-K [ Transition Report on Form 10-Q [ Transition Report on Form N-SAR For the Transi]
